These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23665160)

  • 41. Author response: Retinal nerve fiber layer thickness measurements in rats with the spectral domain optical coherence tomography.
    Lange K; Bähr M; Hein K
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3570-1. PubMed ID: 22685126
    [No Abstract]   [Full Text] [Related]  

  • 42. Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer.
    Sorge J; Kuhl W; West C; Beutler E
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):906-9. PubMed ID: 3547401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A nucleotide substitution in exon 8 of the glucosylceramidase beta gene is associated with Gaucher disease in sheep.
    Zhou H; Zhang Y; Suter R; Gong H; Fang Q; Zhou P; Hickford JGH
    Anim Genet; 2017 Dec; 48(6):733-734. PubMed ID: 29023809
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
    El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
    J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Who seeks finds. Gaucher's disease: a rare case of thrombocytopenia.
    Sgherza N; Quarta A; Rinaldi E; Pasanisi A; Brocca M; Pastore D
    Int J Hematol; 2020 Mar; 111(3):327-328. PubMed ID: 31933165
    [No Abstract]   [Full Text] [Related]  

  • 47. Intrauterine onset of acute neuropathic type 2 Gaucher disease: identification of a novel insertion sequence.
    Felderhoff-Mueser U; Uhl J; Penzel R; Van Landeghem F; Vogel M; Obladen M; Kopitz J
    Am J Med Genet A; 2004 Jul; 128A(2):138-43. PubMed ID: 15214004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel point mutation (W184R) in neonatal type 2 Gaucher disease.
    Choy FY; Wong K; Vallance HD; Baldwin V
    Pediatr Dev Pathol; 2000; 3(2):180-3. PubMed ID: 10679038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.
    Sidransky E; Tayebi N; Stubblefield BK; Eliason W; Klineburgess A; Pizzolato GP; Cox JN; Porta J; Bottani A; DeLozier-Blanchet CD
    J Med Genet; 1996 Feb; 33(2):132-6. PubMed ID: 8929950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to Choi et al. regarding the use of a Gaucher diagnostic kit.
    Navot N; Yakir A; Tchelet A
    Mol Genet Metab; 2010 Jun; 100(2):213. PubMed ID: 20299260
    [No Abstract]   [Full Text] [Related]  

  • 51. Gaucher disease phenotypes outflanked?
    Beutler E
    Genome Res; 1997 Oct; 7(10):950-1. PubMed ID: 9331364
    [No Abstract]   [Full Text] [Related]  

  • 52. Parkinsonism, dementia and glucocerebrosidase mutations.
    Peall K; Robertson NP
    J Neurol; 2013 May; 260(5):1441-4. PubMed ID: 23620067
    [No Abstract]   [Full Text] [Related]  

  • 53. Hematologically important mutations: Gaucher disease.
    Beutler E; Gelbart T
    Blood Cells Mol Dis; 1998 Mar; 24(1):2-8. PubMed ID: 9516376
    [No Abstract]   [Full Text] [Related]  

  • 54. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease.
    Sinclair GB; Jevon G; Colobong KE; Randall DR; Choy FY; Clarke LA
    Mol Genet Metab; 2007 Feb; 90(2):148-56. PubMed ID: 17079175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
    Goebl A; Ferrier RA; Ferreira P; Pinto-Rojas A; Matshes E; Choy FY
    Pediatr Dev Pathol; 2011; 14(3):240-3. PubMed ID: 20946052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gaucher disease in Tunisia: High frequency of the most common mutations.
    Cherif W; Ben Turkia H; Ben Rhouma F; Riahi I; Chemli J; Kefi R; Messai H; Amaral O; Miranda MC; Caillaud C; Tebib N; Ben Dridi MF; Abdelhak S
    Blood Cells Mol Dis; 2009; 43(2):161-2. PubMed ID: 19553144
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical evaluation of sibling pairs with gaucher disease discordant for parkinsonism.
    Lopez G; Steward A; Ryan E; Groden C; Wiggs E; Segalà L; Monestime GM; Tayebi N; Sidransky E
    Mov Disord; 2020 Feb; 35(2):359-365. PubMed ID: 31785030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S.
    Offman MN; Krol M; Silman I; Sussman JL; Futerman AH
    J Biol Chem; 2010 Dec; 285(53):42105-14. PubMed ID: 20980259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of Gaucher Disease Mutations in Parkinson Disease.
    Vilageliu L; Grinberg D
    Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gaucher disease.
    Beutler E
    Curr Opin Hematol; 1997 Jan; 4(1):19-23. PubMed ID: 9050375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.